Iradimed Corporation (NASDAQ:IRMD) Shares Sold by HighTower Advisors LLC

HighTower Advisors LLC cut its stake in shares of Iradimed Corporation (NASDAQ:IRMD) by 20.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 82,356 shares of the medical equipment provider’s stock after selling 20,644 shares during the quarter. HighTower Advisors LLC owned about 0.65% of Iradimed worth $4,142,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in IRMD. Comerica Bank lifted its stake in Iradimed by 2,151.6% during the 1st quarter. Comerica Bank now owns 1,441 shares of the medical equipment provider’s stock valued at $63,000 after acquiring an additional 1,377 shares during the period. Sequoia Financial Advisors LLC acquired a new stake in Iradimed during the 2nd quarter worth about $568,000. 1620 Investment Advisors Inc. purchased a new position in shares of Iradimed during the 2nd quarter valued at about $25,000. Bank of New York Mellon Corp lifted its holdings in shares of Iradimed by 8.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 57,971 shares of the medical equipment provider’s stock valued at $2,547,000 after buying an additional 4,363 shares during the period. Finally, Bailard Inc. purchased a new stake in shares of Iradimed in the second quarter worth about $202,000. Hedge funds and other institutional investors own 92.34% of the company’s stock.

Insider Activity at Iradimed

In other Iradimed news, CFO John Glenn sold 2,500 shares of Iradimed stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $54.18, for a total value of $135,450.00. Following the completion of the transaction, the chief financial officer now owns 4,383 shares of the company’s stock, valued at approximately $237,470.94. The trade was a 36.32 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 37.10% of the company’s stock.

Iradimed Stock Down 0.2 %

Iradimed stock opened at $55.19 on Thursday. Iradimed Corporation has a 52 week low of $40.18 and a 52 week high of $57.95. The firm has a market cap of $699.26 million, a price-to-earnings ratio of 37.80 and a beta of 0.82. The business’s 50-day moving average price is $52.42 and its 200 day moving average price is $47.81.

Iradimed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Friday, November 15th were paid a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 1.09%. The ex-dividend date of this dividend was Friday, November 15th. Iradimed’s dividend payout ratio is currently 41.10%.

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.